Related Experiment Video
Updated: May 14, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children
Ana L Creo1, Joshua S Rosen, Adolfo J Ariza
1Department of Pediatrics, Mayo Eugenio Litta Children's Hospital, Rochester, MN, USA.
Insights
In young obese children, 25-hydroxyvitamin D (25-OHD) levels were not linked to insulin resistance or cardiovascular risks. Factors like age, race, and season predict low vitamin D, guiding management in pediatric obesity care.
Area of Science:
- Pediatric Endocrinology
- Nutritional Science
- Cardiovascular Health
Background:
- Obesity in children is a growing concern, often associated with metabolic and cardiovascular risks.
- Vitamin D deficiency is prevalent and may influence metabolic health, but its role in obese children requires further investigation.
Purpose of the Study:
- To investigate the association between 25-hydroxyvitamin D (25-OHD) levels and markers of insulin resistance and cardiovascular risk in young obese children.
- To identify clinical factors associated with low 25-OHD levels in this pediatric population.
Main Methods:
- Analysis of data from 83 children (ages 2-6 years) receiving obesity care.
- Correlation statistics were used to examine relationships between 25-OHD, insulin resistance (HOMA-IR), and cardiovascular risk factors.
- Chi-squared and logistic regression models identified factors associated with vitamin D deficiency (<20 ng/mL) and insufficiency (<30 ng/mL).
Main Results:
- No significant correlations were found between 25-OHD levels and BMI, BMI Z-score, HOMA-IR, total cholesterol, or triglycerides.
- Vitamin D deficiency was linked to older age, lower milk intake, and winter testing.
- Low 25-OHD levels (<30 ng/mL) were associated with older age, African-American and Hispanic ethnicity, and winter testing, with race/ethnicity being strong predictors.
Conclusions:
- In this cohort of young obese children, 25-OHD levels were not associated with insulin resistance or cardiovascular risk markers.
- Clinical factors including age, race/ethnicity, dietary habits (milk intake), and season of testing are important considerations for identifying children needing vitamin D assessment and management.
Objective:
To examine the relationships of 25-hydroxyvitamin D (25-OHD) levels with the measures of insulin resistance and cardiovascular risk, and identify the clinical factors associated with low 25-OHD in young obese children.
Design And Methods:
Data from 83 children ages 2-6 years seen for obesity care (clinic latitude 42°N) were analyzed. Insulin resistance [homeostasis model assessment of insulin resistance (HOMA-IR)] and cardiovascular risks were examined in relationship to 25-OHD levels using correlation statistics. χ2 and logistic regression models were applied to identify the factors associated with vitamin D deficiency (25-OHD levels <20 ng/mL) and insufficiency (<30 ng/mL).
Results:
Children's mean age was mean 4.9 years and they were predominantly Hispanic. Mean body mass index (BMI) Z-score was 3.2 and mean HOMA-IR was 2.8. Mean 25-OHD was 30.9 ng/mL (6% <20 ng/mL and 46% 20-29 ng/mL). There were no significant correlations between 25-OHD and BMI (Spearman's ρ=-0.096, p=0.389), BMI Z-score (Spearman's ρ=0.104, p=0.350), HOMA-IR (Spearman's ρ=-0.144, p=0.269), total cholesterol (Spearman's ρ=-0.028, p=0.833), or triglycerides (Spearman's ρ=-0.026, p=0.846). Vitamin D deficiency was significantly associated with older age, lower milk intake, and testing in winter months. 25-OHD level <30 ng/mL was associated with older age, African-American and Hispanic race/ethnicity, and testing in winter months. All factors retained significance in a multivariate logistic regression model, with African-American (odds ratio=14.4) and Hispanic (odds ratio=7.2) race/ethnicity being the strongest predictors of 25-OHD levels <30 ng/mL.
Conclusions:
In these children, 25-OHD was not associated with insulin resistance or cardiovascular risks. Considering age, race/ethnicity, diet, and season may help identify young obese children needing vitamin D management.
More Related Videos
Related Concept Videos
Obesity
Type II Diabetes I: Introduction
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Diabetes: Symptoms, Diagnosis, and Complications
Drug Dosing: Obese Patients
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

